A private PSA blood test costs around £50–£100, and it's included in most private health checks. There's no NHS screening programme for prostate cancer — deliberately, because PSA produces false positives and false negatives — though men over 50 can request the test free from their GP. Used well, with informed expectations, it's a reasonable check; a raised result starts a pathway, not a diagnosis.
- ✓A private PSA test costs £50–£100, and features in most private health MOTs.
- ✓There's no NHS screening programme — but men 50+ can request a free PSA test from their GP.
- ✓A raised PSA starts a pathway — MRI first, biopsy only if needed — not a cancer diagnosis.
What a private PSA test costs
PSA (prostate-specific antigen) is a simple blood test, and privately it's priced like one: typically £50–£100 as a standalone test from private GPs, hospital outpatient labs and postal blood-test services, with results in a day or two. It's also bundled into almost every private health assessment for men over 40 or 50 — if you're already considering a health MOT, you'll likely get PSA included rather than needing to buy it separately.
One practical point the price doesn't capture: a PSA result needs interpretation. Levels rise naturally with age, and temporarily after exercise (especially cycling), ejaculation, infection or a urine infection — so a bare number from a postal kit is less useful than the same number discussed with a clinician who knows your age-specific range and can decide whether to simply repeat the test in a few weeks. Cheaper isn't better here; tested-plus-interpreted is.
Why there's no NHS screening programme
Unlike breast or bowel cancer, the UK has no national prostate screening programme — and it's not an oversight or a funding gap. The UK National Screening Committee has repeatedly reviewed PSA and concluded the test isn't reliable enough for blanket screening: it misses some significant cancers (false negatives), and it flags many men who don't have cancer, or have slow-growing cancers that would never have harmed them (false positives and overdiagnosis), historically pulling some into biopsies and treatments with real side effects for no benefit.
Instead, the NHS runs an informed choice policy: any man over 50 can request a free PSA test from his GP after a conversation about the pros and cons. That conversation isn't gatekeeping — it's the point. Roughly speaking: most men with a mildly raised PSA don't have cancer, and some men with normal PSA do. A test this ambiguous is worth doing only if you've decided in advance what you'd do with each possible answer.
It's also worth saying: the picture has improved. The modern pathway inserts MRI before biopsy, which filters out many false alarms non-invasively, and active surveillance means low-risk cancers are watched, not over-treated. PSA in 2026 is a better bet than PSA in 2010 — the arguments against screening are weaker than they were, but they haven't vanished.
What happens after a raised result
A raised PSA is the start of a process, not a verdict. The usual sequence: repeat the test after a few weeks (avoiding cycling, ejaculation and infection beforehand), because many mild rises normalise. If it stays raised for your age, the next step is a multiparametric MRI of the prostate — around £700–£1,200 privately, or via urology referral — which shows whether there's anything that actually warrants a biopsy. Many men stop at the MRI with clear results and no needle involved.
| Step | Private cost (self-pay) | Notes |
|---|---|---|
| PSA blood test | £50–£100 | Repeat if raised — many rises normalise |
| Urology consultation | £150–£250 | Interpretation, examination, next steps |
| Multiparametric MRI | £700–£1,200 | Filters out many false alarms before biopsy |
| Prostate biopsy (if MRI warrants) | £1,500–£3,000 | Targeted using MRI findings |
| NHS route via GP | Free | Urology median wait 12.7 weeks (May 2026) |
On timing: the NHS urology median wait is 12.7 weeks (May 2026) for routine referrals, though genuinely suspicious findings move on the urgent cancer pathway. Privately, the whole PSA-to-answer sequence — consultation, MRI, biopsy if needed — typically compresses into two or three weeks. With health insurance, investigation of a raised PSA is generally claimable as diagnostics; and if cancer is found, treatment moves under the policy's cancer and surgical cover.
Want the follow-up covered, not just the test?
Who should think hardest about testing
PSA's value isn't evenly spread. The case for testing is strongest for men at higher risk: black men (roughly double the average lifetime risk, with risk rising from 45), men with a father or brother diagnosed with prostate cancer, and men with known BRCA2 mutations in the family. For these groups, many specialists support starting PSA conversations at 45 rather than 50 — and a £50–£100 annual or biennial test is a defensible habit.
At the other end: for men in their 40s at average risk with no symptoms, a one-off PSA is more likely to generate anxiety than benefit — and for men with urinary symptoms, PSA isn't optional screening at all: new difficulty passing urine, blood in urine or semen, or bone pain warrant a GP appointment this week, where PSA will be part of a proper assessment rather than a standalone gamble.
The honest bottom line
For £50–£100, a PSA test buys real information with real caveats. Taken with informed expectations — ideally alongside a clinician, repeated before panicking, followed by MRI-first investigation if persistently raised — it's a reasonable choice, and close to essential thinking for higher-risk men from 45. Taken as a casual annual number with no plan for an ambiguous answer, it's the health check equivalent of reading tea leaves with a confidence interval.
If you'd rather the whole chain came as one package — GP conversation, fast diagnostics, and cancer cover if the news is bad — that's what health insurance provides: raised-PSA investigation typically runs consultation-to-answer in weeks under outpatient benefits. We compare men's health pathways, health assessment add-ons and cancer cover across Bupa, AXA Health, Aviva, Vitality, WPA and The Exeter as part of every quote.
Frequently asked questions
How much does a private PSA test cost in the UK?
Around £50–£100 as a standalone blood test from private GPs, hospital labs or postal services, with results in a day or two. It's also included in most private health assessments for men, so if you're booking a health MOT anyway, PSA usually comes bundled. Add roughly £150–£250 if you want a private consultation to interpret the result properly.
Can I get a PSA test free on the NHS?
Yes — any man over 50 can request one from his GP under the NHS informed choice policy, after a conversation about the test's pros and cons. There's no automatic screening programme, so you have to ask. Men under 50 at higher risk — black men, family history, BRCA2 — can also discuss earlier testing with their GP.
Why is there no NHS prostate cancer screening programme?
Because PSA isn't accurate enough for blanket screening: it misses some significant cancers and falsely flags many men who don't have cancer or have harmless slow-growing disease, historically leading to unnecessary biopsies and treatment. The UK National Screening Committee has judged the harms outweigh benefits at population level — hence informed individual choice instead. MRI-first pathways have improved the picture, but not yet overturned it.
What is a normal PSA level for my age?
There's no single cutoff — PSA rises naturally with age, and thresholds are age-adjusted: as a rough guide, higher levels are tolerated at 70 than at 50. Results also spike temporarily after cycling, ejaculation or urine infections. That's why a number needs clinical interpretation and often a repeat test, rather than comparison against one universal 'normal'.
My PSA came back raised — do I have prostate cancer?
Probably not — most men with a mildly raised PSA don't have cancer. The standard next steps: repeat the test after a few weeks avoiding cycling, sex and infection; if still raised, a multiparametric MRI shows whether anything warrants a biopsy. Many men stop at a clear MRI. A persistently raised PSA deserves proper urology follow-up, not panic — and not being ignored, either.
What happens after a raised PSA — MRI or biopsy first?
MRI first, in modern practice. A multiparametric prostate MRI (around £700–£1,200 privately) filters out many false alarms non-invasively; biopsy only follows if the scan shows something needing tissue confirmation, and can then be targeted at the exact area. This MRI-first pathway is standard in both NHS and private care and has substantially cut unnecessary biopsies.
Does health insurance cover PSA tests and follow-up?
Routine screening PSA usually isn't covered — insurance covers investigating problems, not well-man checks — though many insurers' health assessment add-ons include it. Where cover earns its keep is after a raised result: urology consultations, MRI and biopsy are generally claimable as diagnostics, compressed into two or three weeks, and cancer treatment falls under the policy's cancer cover if needed.
Should I get a PSA test at 45?
If you're higher risk, it's worth a serious conversation: black men and men with a father or brother diagnosed with prostate cancer carry roughly double average risk, and many specialists support PSA from 45 for these groups, as do men with BRCA2 in the family. At average risk with no symptoms, the case at 45 is weak — the informed-choice age of 50 exists for a reason.
How often should I repeat a private PSA test?
There's no official schedule, since there's no screening programme. A common-sense pattern used by many clinicians: if you've chosen to test and your baseline is reassuring, every one to two years from 50 (or 45 if higher risk), sooner if a result was borderline. A single reading matters less than the trend — a steadily rising PSA is more informative than one static number.
How long is the NHS wait to see a urologist about a raised PSA?
Routine urology referrals have a median wait of 12.7 weeks (May 2026) — though a PSA raised enough to suggest cancer moves on the urgent suspected-cancer pathway, which is much faster. Privately, consultation within days and MRI within a week or two is typical, so the raised-PSA-to-answer journey runs about two to three weeks end to end.